Blue Water Vaccines, Inc. (BWV) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 1 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for BWV is $4.00, representing a +2,119.8% upside from the current price of $0.1802. Price targets range from a low of $4.00 to a high of $4.00.
